BioCentury | Sep 1, 2014
Company News

Fscan, Glide Pharma deal

...granted Glide exclusive, worldwide rights to technology to develop and commercialize a prostate cancer diagnostic. FScan...
...prostate cancer and seek regulatory approval in the U.S. and Europe. Durham University spun off FScan...
...partners could not be reached for details. The partners could not be reached for details. FScan Ltd....
Items per page:
1 - 1 of 1
BioCentury | Sep 1, 2014
Company News

Fscan, Glide Pharma deal

...granted Glide exclusive, worldwide rights to technology to develop and commercialize a prostate cancer diagnostic. FScan...
...prostate cancer and seek regulatory approval in the U.S. and Europe. Durham University spun off FScan...
...partners could not be reached for details. The partners could not be reached for details. FScan Ltd....
Items per page:
1 - 1 of 1